SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,604.22 -63.41
(-0.59%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

246.67

56.43

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

emmessar biotech & nutrition ltd

Hindustan Unilever consolidated net profit rises 121.41% in the December 2025 quarter

Feb 12,2026

Net profit of Hindustan Unilever rose 121.41% to Rs 6607.00 crore in the quarter ended December 2025 as against Rs 2984.00 crore during the previous quarter ended December 2024. Sales rose 5.74% to Rs 16235.00 crore in the quarter ended December 2025 as against Rs 15353.00 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	16235.00	15353.00	6
OPM %	23.29	24.03	-
PBDT	3832.00	3813.00	0
PBT	3495.00	3495.00	0
NP	6607.00	2984.00	121

79,273.33 753.03 ( 0.96%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,604.22 -63.41 (-0.59%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)